Chronic Urticaria in Africa, What We Know and What We Do Not: A Systematic Review

被引:0
|
作者
Day, Cascia [1 ,2 ]
Peter, Jonny [1 ,2 ]
机构
[1] Univ Cape Town, Fac Hlth Sci, Dept Med, Div Allergy & Clin Immunol, Cape Town, South Africa
[2] Univ Cape Town, Lung Inst, Allergy & Immunol Unit, Cape Town, South Africa
基金
英国医学研究理事会;
关键词
Urticaria; Chronic urticaria; Chronic spontaneous urticaria; Chronic inducible urticaria; Angioedema; Africa; Sub-Saharan Africa; SKIN DISEASES; PREVALENCE; NATIONWIDE; CHILDREN; NIGERIA; PROFILE; PATTERN; IMMUNE; FOOD;
D O I
10.1007/s40521-024-00380-x
中图分类号
R392 [医学免疫学];
学科分类号
100102 ;
摘要
Purpose of Review Despite global incidence, considerable morbidity, and diverse triggers, CU is poorly characterized amongst diverse African populations. This systematic review aims to describe available African CU studies and unmet needs. Recent Findings Overall 221 publications were screened and 29 were eligible for full review. These publications represented only 12 of 54 African countries, with 38% from Nigeria. Most publications described CU within the context of dermatology out-patient clinics(21/29), with a CU prevalence of 0.03-10.4%. Two studies detailed CU demographics, with a female predominance and median age of 30-40 years. CU patients reported variable associations with infections, including T.canis(Egypt), and H.pylori(Nigeria and South Africa), with other risk factors including foods, food additives, and low vitamin D levels. UAS was reported for < 100 CU patients, and only two studies detailed and CU co-morbidities, while none addressed other patient-reported outcome or quality-of-life measures, treatment access and/or efficacy. Summary Despite considerable disease prevalence, CU is poorly detailed in African populations. Further CU studies are required to detail phenotypes, disease severity and describe treatment use and unmet needs.
引用
收藏
页数:14
相关论文
共 50 条
  • [31] Survey of paediatric intravenous fluid prescription: Are we safe in what we know and what we do?
    Keijzers, Gerben
    McGrath, Melissa
    Bell, Christa
    EMERGENCY MEDICINE AUSTRALASIA, 2012, 24 (01) : 86 - 97
  • [32] What do we learn from a cohort of 219 French patients with chronic urticaria?
    Emmanuelle Amsler
    Angèle Soria
    Amandine Vial-Dupuy
    European Journal of Dermatology, 2014, 24 : 700 - 701
  • [33] Islet Cell Autoimmunity in Diabetes: we know, what we do not know
    Kordonouri, O.
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2014, 139 (21) : 1105 - 1105
  • [34] A Narrative Review on Stress and Itch: What We Know and What We Would Like to Know
    Khalil, Nicole B.
    Coscarella, Giulia
    Dhabhar, Firdaus S.
    Yosipovitch, Gil
    JOURNAL OF CLINICAL MEDICINE, 2024, 13 (22)
  • [35] Dysfunctional breathing: what do we know?
    Vidotto, Lais Silva
    Fernandes de Carvalho, Celso Ricardo
    Harvey, Alex
    Jones, Mandy
    JORNAL BRASILEIRO DE PNEUMOLOGIA, 2019, 45 (01)
  • [36] Parenteral nutrition-associated cholestasis - What do we know, what can we do?
    Krawinkel, MB
    EUROPEAN JOURNAL OF PEDIATRIC SURGERY, 2004, 14 (04) : 230 - 234
  • [37] Bangladeshi Militants: What Do We Know?
    Riaz, Ali
    Parvez, Saimum
    TERRORISM AND POLITICAL VIOLENCE, 2018, 30 (06) : 944 - 961
  • [38] Bruxism in children: What do we know? Narrative Review of the current evidence
    Storari, M.
    Serri, M.
    Aprile, M.
    Denotti, G.
    Viscuso, D.
    EUROPEAN JOURNAL OF PAEDIATRIC DENTISTRY, 2023, 24 (03) : 207 - 210
  • [39] Ticks and Tularemia: Do We Know What We Don't Know?
    Zellner, Briana
    Huntley, Jason F.
    FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY, 2019, 9
  • [40] Ketogenic diet, epilepsy and cognition: what do we know so far? A systematic review
    Lima, Maiara Cristina
    Gabiatti, Mariana Papini
    Moreira, Julia Dubois
    Ribeiro, Leticia Carina
    Lunardi, Mariana dos Santos
    Lin, Katia
    Venske, Debora Kurrle
    NUTRITION REVIEWS, 2022, 80 (10) : 2064 - 2075